The Scandinavian Prostate Cancer Group (SPCG) is a group of scientific researchers who have conducted a series of clinical trials of treatments for prostate cancer.[1][2] The group was founded in 1981 and the first study, SPCG-1, began in 1984.[1]
^ abHedlund PO (1999). "The Scandinavian Prostatic Cancer Group. A short review of its history and work". Scand J Urol Nephrol Suppl. 33 (203): 53–6. doi:10.1080/003655999750016285-2. PMID 10636572.
^Høisaeter PA, Vaage S, Hedlund PO (2003). "Clinical research done by the Scandinavian Prostate Cancer Group during the first 20 years". Scand J Urol Nephrol Suppl. 37 (212): 7–10. doi:10.1080/03008880310006878. PMID 12841320.
and 27 Related for: Scandinavian Prostate Cancer Group information
The ScandinavianProstateCancerGroup (SPCG) is a group of scientific researchers who have conducted a series of clinical trials of treatments for prostate...
Active surveillance is a management option for localized prostatecancer that can be offered to appropriate patients who would also be candidates for...
Treatment for prostatecancer may involve active surveillance, surgery, radiation therapy – including brachytherapy (prostate brachytherapy) and external-beam...
in the treatment of metastatic prostaticcancer -- ScandinavianProstaticCancerGroup (SPCG) Study No. 5". Scandinavian Journal of Urology and Nephrology...
treatment for testicular cancer as part of gender-affirming surgery for transgender women as management for advanced prostatecancer to remove damaged testes...
others, is an antiandrogen medication that is primarily used to treat prostatecancer. It is typically used together with a gonadotropin-releasing hormone...
external beam radiotherapy (EBRT) for prostatecancer have a higher risk of developing invasive bladder cancer. In addition to these major risk factors...
De Pauw M, Sylvester R (1980). "EORTC protocols in prostaticcancer. An interim report". Scandinavian Journal of Urology and Nephrology. 55 (Supplementum):...
Bicalutamide can paradoxically stimulate late-stage prostatecancer due to accumulated mutations in the cancer. When used as a monotherapy, bicalutamide can...
irreversible electroporation in the focal treatment of prostatecancer". ProstateCancer and Prostatic Diseases. 17 (4): 343–7. doi:10.1038/pcan.2014.33....
is used primarily in the treatment of prostatecancer in men. It is also used in women to treat breast cancer, as a component of hormone therapy to treat...
limb occurs in up to 41% of patients after gynecologic cancer. For men treated for prostatecancer, a 5-66% incidence has been reported, with the incidence...
(June 2011). "Serum phospholipid fatty acids and prostatecancer risk: results from the prostatecancer prevention trial". American Journal of Epidemiology...
greater rates of obesity. Rates of colorectal, breast, prostate, endometrial and lung cancer started increasing after this dietary change. People in...
treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The ScandinavianProstaticCancerGroup (SPCG)-5 Trial Study"...
2014). "Diethylstilboestrol for the treatment of prostatecancer: past, present and future". Scandinavian Journal of Urology. 48 (1): 4–14. doi:10.3109/21681805...
gastric cancer, hepatocellular carcinoma, and possibly prostatecancer. They appear to have no effect on the risk of lung cancer, kidney cancer, breast...
factor-1α is significantly correlated with poor prognosis of human prostatecancer". Scandinavian Journal of Urology and Nephrology. 44 (5): 277–83. doi:10.3109/00365599...
"Prostate specific acid phosphatase versus five other possible tumor markers: a comparative study in men with prostatic carcinoma". Scandinavian Journal...
Castrate-Resistant ProstateCancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen: Efficacy and Safety in Routine Practice". Cancer Biotherapy and...
type II diabetes, hyperlipidemia, metabolic syndrome, hypothyroidism, prostate hyperplasia and infertility. Habitual chewing of areca nuts increases the...
diagnosed with prostatecancer. He underwent surgery in 2012. His prostate was removed and he was subsequently declared free of cancer. On June 29, 2022...